Tizona Therapeutics' Series B Round

Tizona Therapeutics raised a round of funding on March 08, 2016.

Tizona Therapeutics is a privately held immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune disorders. A healthy immune system integrates infor…

Articles about Tizona Therapeutics' Series B Round: